DEAD

Serial Number

90240385

Owner

Genesis Drug Discovery & Development, LLC

Attorney

Arnold Braun

Filing Date

Oct 7, 2020

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

IMMUNOVEDA Trademark

Serial Number: 90240385

IMMUNOVEDA is a trademark filed by Genesis Drug Discovery & Development, LLC on October 7, 2020. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Genesis Drug Discovery & Development, LLC (14 trademarks)

2439 Kuser Road
Hamilton, NJ 08690

Entity Type: 16

Legal Representation

Attorney of Record

Arnold Braun

55 trademarks filed View all →

Correspondence Address

/Arnold Braun/ GENESIS BIOTECHNOLOGY GROUP. LLC

2439 KUSER ROAD

HAMILTON

NJ 08690

UNITED STATES

Trademark Details

Filing Date

October 7, 2020

Registration Date

Not Registered

Published for Opposition

April 13, 2021

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Sep 1, 2023 MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Sep 1, 2023 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Sep 1, 2023 ABN2

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 18, 2023 GNRN

NON-FINAL ACTION E-MAILED

May 18, 2023 GNRT

SU - NON-FINAL ACTION - WRITTEN

May 18, 2023 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Apr 24, 2023 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 24, 2023 AITU

USE AMENDMENT FILED

Apr 4, 2023 IUAF

TEAS STATEMENT OF USE RECEIVED

Apr 4, 2023 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 16, 2022 EXRA

SOU EXTENSION 3 GRANTED

Sep 14, 2022 EX3G

SOU EXTENSION 3 FILED

Sep 14, 2022 EXT3

SOU TEAS EXTENSION RECEIVED

Sep 14, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 2, 2022 EXRA

SOU EXTENSION 2 GRANTED

May 31, 2022 EX2G

SOU EXTENSION 2 FILED

May 31, 2022 EXT2

SOU TEAS EXTENSION RECEIVED

May 31, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 24, 2021 EXRA

SOU EXTENSION 1 GRANTED

Nov 22, 2021 EX1G

SOU EXTENSION 1 FILED

Nov 22, 2021 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 22, 2021 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 8, 2021 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 13, 2021 NPUB

PUBLISHED FOR OPPOSITION

Apr 13, 2021 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 24, 2021 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 9, 2021 CNSA

EXAMINER'S AMENDMENT ENTERED

Mar 9, 2021 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 9, 2021 GNEN

EXAMINERS AMENDMENT E-MAILED

Mar 9, 2021 GNEA

EXAMINERS AMENDMENT -WRITTEN

Mar 9, 2021 CNEA

ASSIGNED TO EXAMINER

Mar 5, 2021 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 21, 2020 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 20, 2020 NWOS

NEW APPLICATION ENTERED

Oct 10, 2020 NWAP

Related Trademarks

More from this Owner

IMMUNOVEDA

More in Same Class

HELIOS TELEMEDICINE FOR MEN